Overview A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease Status: Unknown status Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the efficacy and safety of V565 in participants with active Crohn's Disease. Phase: Phase 2 Details Lead Sponsor: VHsquared Ltd.